These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


232 related items for PubMed ID: 7737774

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate.
    Momeni AZ, Reiszadae MR, Aminjavaheri M.
    Int J Dermatol; 2002 Jul; 41(7):441-3. PubMed ID: 12121563
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV.
    Laguna F, López-Vélez R, Soriano V, Montilla P, Alvar J, González-Lahoz JM.
    J Infect; 1994 May; 28(3):255-9. PubMed ID: 8089514
    [Abstract] [Full Text] [Related]

  • 9. Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy.
    Shamsi Meymandi S, Javadi A, Dabiri S, Shamsi Meymandi M, Nadji M.
    Arch Iran Med; 2011 Jul; 14(4):238-43. PubMed ID: 21726098
    [Abstract] [Full Text] [Related]

  • 10. Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
    Esfandiarpour I, Alavi A.
    Int J Dermatol; 2002 Aug; 41(8):521-4. PubMed ID: 12207774
    [Abstract] [Full Text] [Related]

  • 11. Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial.
    Firooz A, Khamesipour A, Ghoorchi MH, Nassiri-Kashani M, Eskandari SE, Khatami A, Hooshmand B, Gorouhi F, Rashighi-Firoozabadi M, Dowlati Y.
    Arch Dermatol; 2006 Dec; 142(12):1575-9. PubMed ID: 17178983
    [Abstract] [Full Text] [Related]

  • 12. Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial.
    Velez I, Agudelo S, Hendrickx E, Puerta J, Grogl M, Modabber F, Berman J.
    Ann Intern Med; 1997 Feb 01; 126(3):232-6. PubMed ID: 9027276
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis.
    Arevalo I, Tulliano G, Quispe A, Spaeth G, Matlashewski G, Llanos-Cuentas A, Pollack H.
    Clin Infect Dis; 2007 Jun 15; 44(12):1549-54. PubMed ID: 17516397
    [Abstract] [Full Text] [Related]

  • 15. Dressings combined with injection of meglumine antimoniate in the treatment of cutaneous leishmaniasis: a randomized controlled clinical trial.
    Khatami A, Talaee R, Rahshenas M, Khamesipour A, Mehryan P, Tehrani S, Dowlati Y, Firooz A.
    PLoS One; 2013 Jun 15; 8(6):e66123. PubMed ID: 23826087
    [Abstract] [Full Text] [Related]

  • 16. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru.
    Miranda-Verástegui C, Llanos-Cuentas A, Arévalo I, Ward BJ, Matlashewski G.
    Clin Infect Dis; 2005 May 15; 40(10):1395-403. PubMed ID: 15844060
    [Abstract] [Full Text] [Related]

  • 17. Systemic Meglumine Antimoniate in Cutaneous Leishmaniasis of Children: Clinical and Laboratory Complications.
    Layegh P, Khademi Z, Afzal Aghaee M, Moghiman T.
    J Pediatric Infect Dis Soc; 2015 Dec 15; 4(4):356-8. PubMed ID: 26582874
    [Abstract] [Full Text] [Related]

  • 18. Intralesional treatment of cutaneous leishmaniasis with meglumine antimoniate.
    Aste N, Pau M, Ferreli C, Biggio P.
    Br J Dermatol; 1998 Feb 15; 138(2):370-1. PubMed ID: 9602904
    [No Abstract] [Full Text] [Related]

  • 19. Chronic zosteriform cutaneous leishmaniasis.
    Omidian M, Mapar MA.
    Indian J Dermatol Venereol Leprol; 2006 Feb 15; 72(1):41-2. PubMed ID: 16481709
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.